Schizophrenia
Phase III Data on Anti-Psychotic Aripiprazole Presented
Published in Neurological Diseases and Disorders Weekly, June 1st, 2000
Aripiprazole was also shown to be better tolerated than haloperidol.
The results of the study were presented during the Annual Meeting of the American Psychiatric Association in May 2000.
"We are very excited about the first Phase III study results with aripiprazole," said Peter S. Ringrose, PhD, Bristol-Myers Squibb Co. (BMY). "Our partner Otsuka has discovered a potentially best-in-class agent for the treatment of schizophrenia, and we hope that this drug...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Neurological Diseases and Disorders Weekly
More Articles from Neurological Diseases and Disorders Weekly
- Alzheimer's Disease
Triggering Enzyme Identified - Alzheimer's Disease
Circadian Rhythm Disturbances Located in the Suprachiasmatic Nucleus - Animal Models
Rat Anatomy Textbooks May Be Wrong About Spinal Nerves - Antinociception
Melatonin Pain Relief is Mediated by MT2 Receptors - Attention Deficit/Hyperactivity Disorder
Adderall More Effective than Methylphenidate in Reducing Symptoms - Brain Function
Researchers Discover New Synapses - More from this issue of Neurological Diseases and Disorders Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
